These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12354469)

  • 21. Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: a decision analysis.
    Grann VR; Jacobson JS; Whang W; Hershman D; Heitjan DF; Antman KH; Neugut AI
    Cancer J Sci Am; 2000; 6(1):13-20. PubMed ID: 10696733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Timing of familial breast cancer in sisters.
    Rebora P; Czene K; Reilly M
    J Natl Cancer Inst; 2008 May; 100(10):721-7. PubMed ID: 18477799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proven non-carriers in BRCA families have an earlier age of onset of breast cancer.
    Vos JR; de Bock GH; Teixeira N; van der Kolk DM; Jansen L; Mourits MJ; Oosterwijk JC
    Eur J Cancer; 2013 Jun; 49(9):2101-6. PubMed ID: 23490645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Familial prostate cancer and possible associated malignancies: nation-wide register cohort study in Sweden.
    Damber L; Grönberg H; Damber JE
    Int J Cancer; 1998 Oct; 78(3):293-7. PubMed ID: 9766560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families.
    Harvey SL; Milne RL; McLachlan SA; Friedlander ML; Birch KE; Weideman P; ; Goldgar D; Hopper JL; Phillips KA
    Breast Cancer Res Treat; 2011 Dec; 130(3):1057-61. PubMed ID: 21850394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer.
    Couch FJ; DeShano ML; Blackwood MA; Calzone K; Stopfer J; Campeau L; Ganguly A; Rebbeck T; Weber BL
    N Engl J Med; 1997 May; 336(20):1409-15. PubMed ID: 9145677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
    Gallardo M; Silva A; Rubio L; Alvarez C; Torrealba C; Salinas M; Tapia T; Faundez P; Palma L; Riccio ME; Paredes H; Rodriguez M; Cruz A; Rousseau C; King MC; Camus M; Alvarez M; Carvallo P
    Breast Cancer Res Treat; 2006 Jan; 95(1):81-7. PubMed ID: 16261400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Family history of breast cancer as a risk factor for ovarian cancer in a prospective study.
    Kazerouni N; Greene MH; Lacey JV; Mink PJ; Schairer C
    Cancer; 2006 Sep; 107(5):1075-83. PubMed ID: 16881078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers.
    Metcalfe KA; Lynch HT; Ghadirian P; Tung N; Olivotto IA; Foulkes WD; Warner E; Olopade O; Eisen A; Weber B; McLennan J; Sun P; Narod SA
    Gynecol Oncol; 2005 Jan; 96(1):222-6. PubMed ID: 15589605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.
    King MC; Marks JH; Mandell JB;
    Science; 2003 Oct; 302(5645):643-6. PubMed ID: 14576434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [In cases of familial ovarian cancer, always consider the risk of breast cancer].
    Kets CM; Niermeijer MF; Massuger LF; Hoogerbrugge N
    Ned Tijdschr Geneeskd; 2004 Aug; 148(35):1709-11. PubMed ID: 15468897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Family history of breast or ovarian cancer modifies the risk of secondary leukemia after breast cancer: results from a population-based study.
    Verkooijen HM; Fioretta G; Rapiti E; Vlastos G; Neyroud-Caspar I; Chappuis PO; Bouchardy C
    Int J Cancer; 2008 Mar; 122(5):1114-7. PubMed ID: 17973260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of parity and ovarian cancer risk by family history of breast or ovarian cancer in a population-based study of postmenopausal women.
    Vachon CM; Mink PJ; Janney CA; Sellers TA; Cerhan JR; Hartmann L; Folsom AR
    Epidemiology; 2002 Jan; 13(1):66-71. PubMed ID: 11805588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of in situ breast cancer and family history on risk of subsequent breast cancer events and mortality - a population-based study from Sweden.
    Sackey H; Hui M; Czene K; Verkooijen H; Edgren G; Frisell J; Hartman M
    Breast Cancer Res; 2016 Oct; 18(1):105. PubMed ID: 27756431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The genetic epidemiology of second primary breast cancer.
    Bernstein JL; Thompson WD; Risch N; Holford TR
    Am J Epidemiol; 1992 Oct; 136(8):937-48. PubMed ID: 1456270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A nationwide population-based retrospective cohort study of the risk of uterine, ovarian and breast cancer in women with polycystic ovary syndrome.
    Shen CC; Yang AC; Hung JH; Hu LY; Tsai SJ
    Oncologist; 2015 Jan; 20(1):45-9. PubMed ID: 25410097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk-adapted starting age of breast cancer screening in women with a family history of ovarian or other cancers: A nationwide cohort study.
    Mukama T; Kharazmi E; Sundquist K; Sundquist J; Fallah M
    Cancer; 2021 Jun; 127(12):2091-2098. PubMed ID: 33620751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cohort study of reproductive factors and family history of breast cancer in southern Sweden.
    Olsson H; Bladström A
    Breast Cancer Res Treat; 2002 Dec; 76(3):203-9. PubMed ID: 12462381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of body fat distribution and family histories of breast and ovarian cancer with risk of postmenopausal breast cancer.
    Sellers TA; Gapstur SM; Potter JD; Kushi LH; Bostick RM; Folsom AR
    Am J Epidemiol; 1993 Nov; 138(10):799-803. PubMed ID: 8237968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation.
    Williams CL; Jones ME; Swerdlow AJ; Botting BJ; Davies MC; Jacobs I; Bunch KJ; Murphy MFG; Sutcliffe AG
    BMJ; 2018 Jul; 362():k2644. PubMed ID: 29997145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.